Avicanna to present at the Q1 Virtual Investor Summit
Rhea-AI Summary
Avicanna (AVCNF) announces CEO Aras Azadian's participation in the upcoming Q1 Virtual Investor Summit from March 23-25, 2021. Azadian's presentation is scheduled for March 24 at 2:00 PM ET. The summit is designed to connect smallcap and microcap companies with over 300 institutional and retail investors, featuring 100 participating companies. Interested investors can register for free at www.investorsummitgroup.com.
Positive
- None.
Negative
- None.
News Market Reaction – AVCNF
In the trading session that priced this news, AVCNF gained 3.00%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TORONTO, March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire- Avicanna (AVCNF) today announced that Aras Azadian, CEO, will be attending the Q1 Virtual Investor Summit.
| Event | Q1 Investor Summit | ||
| Date | March 23-25th, 2021 | ||
| Presentation | March 24th @ 2:00PM ET | ||
| Location | https://zoom.us/webinar/register/WN_gqM8YnegRIqpec0qI9JuVw |
About The Investor Summit
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 100 companies and over 300 institutional and retail investors.
To request complimentary investor registration: please visit our website at www.investorsummitgroup.com
Contact:
Brittney Blocker at brittney@investorsummitgroup.com
ABOUT Avicanna
Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.
Wire Service Contact:
InvestorWire (IW)
Los Angeles, California
212.418.1217 Office
Editor@InvestorWire.com